Late Breaking Abstract - Endobronchial Valves for Severe Emphysema – 12-month Results of the EMPROVE Trial

G. Criner (Philadlephia, United States of America), A. Delage (Quebec City, Canada), K. Voelker (Sarasota, United States of America)

Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT
Session: Interventional pulmonology highlights in 2018: ELVR, TLD and BT
Session type: Oral Presentation
Number: 4928
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Criner (Philadlephia, United States of America), A. Delage (Quebec City, Canada), K. Voelker (Sarasota, United States of America). Late Breaking Abstract - Endobronchial Valves for Severe Emphysema – 12-month Results of the EMPROVE Trial. 4928

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: